L. Rubio

发表

The COVID-19 Symptom to Isolation Cascade in a Latinx Community: A Call to Action

E. Crawford, D. Havlir, C. M. Hoover, 2021, Open forum infectious diseases.

Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19

Angela Oliveira Pisco, Nader Najafi, John R. Haliburton, 2020, EClinicalMedicine.

Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing

J. Derisi, D. Havlir, G. Chamie, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Mark S. Anderson, Chun Jimmie Ye, Gabriela K. Fragiadakis, 2022, Science immunology.

Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco

E. Crawford, J. Derisi, M. Petersen, 2020, medRxiv.

Incidence and Prevalence of Coronavirus Disease 2019 Within a Healthcare Worker Cohort During the First Year of the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic

E. Crawford, M. Desai, C. Craik, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco

E. Crawford, J. Derisi, D. Havlir, 2021, The Journal of infectious diseases.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics and Immune Responses in a Household of Vaccinated Persons

Mark S. Anderson, J. Derisi, D. Havlir, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron

J. Derisi, D. Havlir, M. Laurie, 2022, The Journal of infectious diseases.

SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron

J. Derisi, D. Havlir, M. Laurie, 2021, medRxiv : the preprint server for health sciences.

Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains

J. Derisi, D. Havlir, M. Laurie, 2021, medRxiv.

Experiences of Latinx Individuals Hospitalized for COVID-19

N. Powe, A. Tong, L. Cervantes, 2021, JAMA network open.

High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community

J. Derisi, D. Havlir, G. Chamie, 2021, medRxiv.

A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice

J. Derisi, J. Fuchs, D. Havlir, 2021, medRxiv.

Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco

J. Derisi, M. Petersen, D. Havlir, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco

J. Derisi, M. Petersen, D. Havlir, 2021, medRxiv.

Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19

John R. Haliburton, N. Neff, J. Derisi, 2020, medRxiv.

High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco

D. Havlir, G. Chamie, C. Marquez, 2021, Open forum infectious diseases.

Coccidioidomycosis Presenting with Fever and Back Pain

J. Babik, C. Lucas, L. Rubio, 2020, Journal of General Internal Medicine.

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Mark S. Anderson, Chun Jimmie Ye, P. Gregersen, 2022, Science Immunology.